STEMLOGIC
DEAD

Serial Number

98821547

Owner

Caper Labs, Inc.

Attorney

Isaac M. Fine

Filing Date

Oct 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

STEMLOGIC Trademark

Serial Number: 98821547

STEMLOGIC is a trademark filed by Caper Labs, Inc. on October 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Caper Labs, Inc. (27 trademarks)

1 Letterman Drive, Bldg. C3500
San Francisco, CA 94129

Entity Type: 03

Trademark Details

Filing Date

October 25, 2024

Registration Date

Not Registered

Published for Opposition

April 22, 2025

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF CANCER TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF CHEMOTHERAPY; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF RADIATION THERAPY; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF TARGETED CANCER TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF TARGETED CANCER TREATMENTS, NAMELY, TYROSINE KINASE INHIBITORS; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING SIDE EFFECTS OF IMMUNOTHERAPY TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING GASTROINTESTINAL DISTRESS, MUCOCITIS, NAUSEA, VOMITING AND DIARRHEA; PHARMACEUTICAL PREPARATIONS FOR STIMULATING APPETITE; PHARMACEUTICAL PREPARATIONS FOR PREVENTING WEIGHT LOSS; PHARMACEUTICAL PREPARATIONS FOR PROTECTING BONE MARROW AND THE PRODUCTION OF BONE MARROW; PHARMACEUTICAL PREPARATIONS FOR PROTECTING STEM CELLS AND STIMULATING THE PRODUCTION OF STEM CELLS; PHARMACEUTICAL PREPARATIONS FOR INCREASING RESILIENCY OF STEM CELLS, INCREASING THE NUMBER OF STEM CELLS, AND PREVENTING THE REDUCTION OF STEM CELL POPULATIONS; PHARMACEUTICAL PREPARATIONS FOR PROTECTING BLOOD CELLS, ALLEVIATING ANEMIA, NEUTROPENIA, AND THROMBOCYTOPENIA, AND ALLEVIATING LOW BLOOD COUNT; PHARMACEUTICAL PREPARATIONS FOR ALLEVIATING DOSE LIMITING SIDE EFFECTS OF CANCER TREATMENTS, CHEMOTHERAPY, RADIATION THERAPY, TARGETED CANCER TREATMENTS AND IMMUNOTHERAPY TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF CANCER TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF CHEMOTHERAPY; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF RADIATION THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF TARGETED CANCER TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF TARGETED CANCER TREATMENTS, NAMELY, TYROSINE KINASE INHIBITORS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF IMMUNOTHERAPY TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISTRESS, MUCOCITIS, NAUSEA, VOMITING AND DIARRHEA; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF LOSS OF APPETITE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF WEIGHT LOSS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF BONE MARROW DAMAGE; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF STEM CELL DAMAGE AND REDUCTION OF STEM CELL POPULATIONS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF BLOOD CELL DAMAGE, ANEMIA, NEUTROPENIA, THROMBOCYTOPENIA AND LOW BLOOD COUNT; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF DOSE LIMITING SIDE EFFECTS OF CANCER TREATMENTS, CHEMOTHERAPY, RADIATION THERAPY, TARGETED CANCER TREATMENTS AND IMMUNOTHERAPY TREATMENTS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF CANCER TREATMENTS, CHEMOTHERAPY, RADIATION THERAPY, TARGETED CANCER TREATMENTS AND IMMUNOTHERAPY TREATMENTS, NAMELY, REDUCED FERTILITY; FERTILITY ENHANCEMENT PREPARATIONS; PHARMACEUTICAL PREPARATIONS FOR SUPPORTING STEM CELL HEALTH AND PRODUCTION; PHARMACEUTICAL PREPARATIONS FOR SUPPORTING STEM CELL HEALTH AND PRODUCTION, NAMELY FOR STIMULATING UTERINE, BONE MARROW AND GASTROINTESTINAL TRACK STEM CELL PRODUCTION; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF RADIATION EXPOSURE

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 19, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 19, 2026 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 12, 2025 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 17, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 22, 2025 PUBO
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 18, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 18, 2025 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 26, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2024 NWOS
NEW APPLICATION ENTERED
Oct 25, 2024 NWAP